Biofrontera Inc. — Investor Relations & Filings
Filings indexed
350
across all filing types
Latest filing
2026-03-19
Annual Report
Country
US
United States of America
Listing
US
BFRI
Biofrontera Inc. is a biopharmaceutical company that commercializes a portfolio of pharmaceutical products for the treatment of dermatological conditions. The company specializes in photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used to treat actinic keratoses, a type of pre-cancerous skin lesion, and impetigo, a bacterial skin infection. Biofrontera focuses on establishing PDT as a standard of care in dermatology and utilizes a proprietary nanoemulsion technology to improve the stability and skin penetration of its formulations, potentially increasing clinical efficacy.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-K - Biofrontera Inc. (0001858685) (Filer) | 2026-03-19 | English | |
| 8-K - Biofrontera Inc. (0001858685) (Filer) | 2026-03-19 | English | |
| 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | |
| 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | |
| 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | |
| 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 32989302 | 10-K - Biofrontera Inc. (0001858685) (Filer) | 2026-03-19 | English | ||
| 32986713 | 8-K - Biofrontera Inc. (0001858685) (Filer) | 2026-03-19 | English | ||
| 32911294 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911293 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911292 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911288 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911287 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911284 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911281 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32899942 | 8-K - BIOFRONTERA INC. (0001858685) (Filer) | 2026-02-26 | English | ||
| 32100293 | SCHEDULE 13G/A Filing | 2026-02-11 | English | ||
| 32100370 | 8-K Filing | 2026-02-09 | English | ||
| 32100337 | SCHEDULE 13G/A Filing | 2026-01-28 | English | ||
| 13442747 | 8-K | 2026-01-13 | English | ||
| 13442785 | 8-K | 2026-01-07 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CTC BIO, INC.
Develops and manufactures human and animal health products …
|
060590 | KR | Manufacturing |
|
Cue Biopharma, Inc.
Develops biologics to selectively modulate the immune syste…
|
CUE | US | Manufacturing |
|
Cullinan Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
CGEM | US | Manufacturing |
|
CUMBERLAND PHARMACEUTICALS INC
Acquires, develops, and commercializes branded drugs for ho…
|
CPIX | US | Manufacturing |
|
Cuorips Inc.
Develops iPS cell-derived therapies and provides cell proce…
|
4894 | JP | Manufacturing |
|
Cuprina Holdings (Cayman) LTD
Biomedical firm developing wound care biotherapy and cosmec…
|
CUPR | US | Manufacturing |
|
Curaleaf
Cultivates, processes, and distributes medical and wellness…
|
CURA | CA | Manufacturing |
|
Curanex Pharmaceuticals Inc
Develops botanical drugs for inflammatory diseases like ulc…
|
CURX | US | Manufacturing |
|
Curasight A/S
A clinical-stage biotech developing a theranostic platform …
|
CURAS | DK | Manufacturing |
|
Curevac
A biopharmaceutical company developing therapies based on m…
|
CVAC | NL | Manufacturing |
Biofrontera Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35198/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35198 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35198 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35198 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35198}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Biofrontera Inc. (id: 35198)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.